209 related articles for article (PubMed ID: 17559909)
1. Matrix metalloproteinases-2, -3 and -9 in human term placenta.
Demir-Weusten AY; Seval Y; Kaufmann P; Demir R; Yucel G; Huppertz B
Acta Histochem; 2007; 109(5):403-12. PubMed ID: 17559909
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor.
Xu P; Alfaidy N; Challis JR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1353-61. PubMed ID: 11889208
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
[TBL] [Abstract][Full Text] [Related]
4. Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor.
Yonemoto H; Young CB; Ross JT; Guilbert LL; Fairclough RJ; Olson DM
Placenta; 2006; 27(6-7):669-77. PubMed ID: 16061282
[TBL] [Abstract][Full Text] [Related]
5. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.
Polette M; Nawrocki B; Pintiaux A; Massenat C; Maquoi E; Volders L; Schaaps JP; Birembaut P; Foidart JM
Lab Invest; 1994 Dec; 71(6):838-46. PubMed ID: 7807965
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes.
Walter I; Boos A
Placenta; 2001 May; 22(5):473-83. PubMed ID: 11373158
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans.
Nishihara S; Someya A; Yonemoto H; Ota A; Itoh S; Nagaoka I; Takeda S
Reprod Sci; 2008 Feb; 15(2):156-65. PubMed ID: 18276951
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-2 and MMP-9 activity in the canine uterus before and during placentation.
Beceriklisoy HB; Walter I; Schäfer-Somi S; Miller I; Kanca H; Izgür H; Aslan S
Reprod Domest Anim; 2007 Dec; 42(6):654-9. PubMed ID: 17976075
[TBL] [Abstract][Full Text] [Related]
9. Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor.
Li W; Alfaidy N; Challis JR
J Clin Endocrinol Metab; 2004 Jun; 89(6):2897-904. PubMed ID: 15181074
[TBL] [Abstract][Full Text] [Related]
10. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation.
Pustovrh MC; Jawerbaum A; Capobianco E; White V; López-Costa JJ; González E
Placenta; 2005 Apr; 26(4):339-48. PubMed ID: 15823620
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of messenger RNA expression of matrix metalloproteinases (MMP-2 and MMP-9), tissue inhibitor-2 of matrix metalloproteinases (TIMP-2), and steroidogenic enzymes in bovine placentomes during gestation and postpartum.
Takagi M; Yamamoto D; Ohtani M; Miyamoto A
Mol Reprod Dev; 2007 Jul; 74(7):801-7. PubMed ID: 17154296
[TBL] [Abstract][Full Text] [Related]
12. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in the vein wall.
Kowalewski R; Sobolewski K; Wolanska M; Gacko M
Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix components and matrix degrading enzymes in the feline placenta during gestation.
Walter I; Schönkypl S
Placenta; 2006; 27(2-3):291-306. PubMed ID: 16338474
[TBL] [Abstract][Full Text] [Related]
15. Initial characterization of the microenvironment that regulates connective tissue degradation in amniochorion during normal human labor.
Estrada-Gutierrez G; Zaga V; Gonzalez-Jimenez MA; Beltran-Montoya J; Maida-Claros R; Giono-Cerezo S; Vadillo-Ortega F
Matrix Biol; 2005 Jun; 24(4):306-12. PubMed ID: 15955681
[TBL] [Abstract][Full Text] [Related]
16. Regulation of matrix metalloproteinases 2 and 9 activities by peroxynitrites in term placentas from type 2 diabetic patients.
Capobianco E; White V; Sosa M; Di Marco I; Basualdo MN; Faingold MC; Jawerbaum A
Reprod Sci; 2012 Aug; 19(8):814-22. PubMed ID: 22344735
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatments enriched in olive and safflower oils regulate seric and placental matrix metalloproteinases in maternal diabetes.
Martinez N; Sosa M; Higa R; Fornes D; Capobianco E; Jawerbaum A
Placenta; 2012 Jan; 33(1):8-16. PubMed ID: 22098918
[TBL] [Abstract][Full Text] [Related]
18. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of activities of matrix metalloproteinases-9 and -2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare.
Oddsdóttir C; Riley SC; Leask R; Shaw DJ; Aurich C; Palm F; Fowden AL; Ricketts SW; Watson ED
Theriogenology; 2011 Apr; 75(6):1130-8. PubMed ID: 21220153
[TBL] [Abstract][Full Text] [Related]
20. [Transition from the latent to the active enzymatic form as a model of regulation of extracellular matrix degradation in the chorioamnion during human labor].
Vadillo Ortega F; Hernández Miranda A; Bermejo Martínez L; Beltrán Montoya J; González Avila G
Ginecol Obstet Mex; 1995 Apr; 63():166-72. PubMed ID: 7768474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
